The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...
Abbott Laboratories ABT recently received a new FDA approval with its Proclaim XR spinal cord stimulation system (SCS) for people with chronic pain. This time the regulatory body has approved an ...
LAFAYETTE, Ind. − A Lafayette pain management clinic became the first in the nation to test a noninvasive device that stimulates the spinal cord to help with chronic pain. The Center for Pain ...
NATIONAL HARBOR, MD — Patients with severe chronic pain who undergo implantation with an investigational high-frequency spinal cord stimulation (SCS) device show twice the magnitude of pain relief and ...
The development of more ergonomic, smaller Pulse Generators (IPGs) has significantly improved patient comfort. These smaller devices reduce complications such as "pocket pain" at the implant site.
SAN DIEGO — The next advance in spinal cord stimulation (SCS) could be a closed-loop system that uses evoked compound action potentials (ECAPs) to maintain therapeutic activation, results of the phase ...
St. Jude Medical, Inc., a global medical device company and an international leader in chronic pain therapy development, today announced the European launch of the Proclaim™ Elite Spinal Cord ...
Medical Device Network on MSN
Italy’s WISE raises $34.8m in Series D to advance spinal cord stimulator development
WISE's Heron lead has been designed to deliver targeted, directional stimulation through a minimally invasive percutaneous ...
Spinal cord stimulation (SCS) has been utilized for more than 50 years to treat refractory neuropathic pain. Currently, SCS systems with fully implantable pulse generators (IPGs) represent the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results